StonvexLoading…
StonvexStonvexStonvexCore line items from OTIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.43B | $14.26B | $14.21B | $13.69B |
Operating Income | $2.13B | $2.01B | $2.19B | $2.03B |
Net Income | $1.38B | $1.65B | $1.41B | $1.25B |
EPS (Diluted) | $3.50 | $4.07 | $3.39 | $2.96 |
Total Assets | $10.65B | $11.32B | $10.12B | $9.82B |
Total Liabilities | $15.92B | $16.04B | $14.84B | $14.48B |
Cash & Equivalents | $1.10B | $2.30B | $1.27B | $1.19B |
Free Cash Flow OCF − CapEx | $1.44B | $1.44B | $1.49B | $1.45B |
Shares Outstanding | 394.90M | 438.60M | 437.00M | 435.60M |